thaden.presentation - mnacvpr10/3/16 4 ©2016 mfmer | slide-19 treatment mitral valve repair vs...
TRANSCRIPT
![Page 1: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/1.jpg)
10/3/16
1
©2016 MFMER | slide-1
MitraClip® Therapy: Technique and Implications for Cardiac Rehab
Jeremy Thaden, MD Minnesota Association of Cardiovascular and Pulmonary Rehabilitation
October 7, 2016
©2016 MFMER | slide-2
Disclosures • None
©2016 MFMER | slide-3
Objectives • Learn the normal anatomy and function of the
mitral valve and the basic pathophysiology of mitral regurgitation.
• Learn the natural history of untreated mitral regurgitation and current treatment options.
• Review the transcatheter mitral valve repair (edge-to-edge repair or MitraClip) procedure.
• Discuss common comorbidities and important considerations in post-MitraClip patients undergoing cardiac rehabilitation.
©2016 MFMER | slide-4
Transcatheter Structural Heart Procedures Recent Growth in Volume and Complexity • Transcatheter aortic valve replacement
• Percutaneous paravalvular regurgitation closure
• Left atrial appendage occlusion
• Transcatheter mitral valve repair (edge-to-edge repair; MitraClip)
©2016 MFMER | slide-5
Normal Mitral Valve Structure and Function
©2016 MFMER | slide-6
Mitral Valve Normal Anatomy
![Page 2: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/2.jpg)
10/3/16
2
©2016 MFMER | slide-7
Mitral Valve Normal Anatomy
©2016 MFMER | slide-8
Mitral Regurgitation Abnormal Valve
Primary/Organic MR
Valve Disease Ventricular consequences
Normal Valve
Secondary/ Functional MR
Ventricular disease Valve consequences
©2016 MFMER | slide-9
Assess the Mechanism of Regurgitation Primary Regurgitation
©2016 MFMER | slide-10
Assess the Mechanism of Regurgitation Secondary Regurgitation
©2016 MFMER | slide-11 Nkomo et al. Lancet 2006
Global Burden of Valve Disease Prevalence by Age
©2016 MFMER | slide-12
Nkomo et al. Lancet 2006 Mirabel et al. EHJ 2007
Burden of Mitral Regurgitation Prevalence and Adherence to Guidelines
• 7-10% of individuals ≥75 years of age have ≥moderate mitral regurgitation
• Surgery is pursued in only ~50% of eligible patients
• Reasons patients denied surgery: • Decreased left ventricular ejection fraction • Advanced age • Increased comorbidities • Less severe mitral regurgitation
![Page 3: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/3.jpg)
10/3/16
3
©2016 MFMER | slide-13
Pathophysiology Acute Mitral Regurgitation • Mitral regurgitation enhances
ventricular emptying • Ejection fraction increases • Forward stroke volume
decreases • Markedly increased left atrial
pressure • Pulmonary edema and
congestive heart failure
©2016 MFMER | slide-14
Acute Primary Mitral Regurgitation Flail Posterior Leaflet
©2016 MFMER | slide-15
Pathophysiology Chronic Mitral Regurgitation • The left atrium and left ventricle dilate (eccentric
hypertrophy) due to chronic volume overload • Ejection fraction is increased • Forward stroke volume preserved • Left atrial pressure modestly elevated • Left ventricular dysfunction may be present
despite normal ejection fraction
©2016 MFMER | slide-16 Ling LH et al. N Engl J Med 1996;335:1417-1423.
Incidence of Atrial Fibrillation (AF), Congestive Heart Failure (CHF), Mitral-Valve Surgery, and Surgery or Death.
©2016 MFMER | slide-17
Mitral Valve Surgery for Severe Regurgitation Indications for PRIMARY regurgitation
• Class I (strongest recommendation) • Symptoms • LV ejection fraction <60% or LVESD ≥40 mm
• Class IIa (should do for most patients) • Asymptomatic with high likelihood of repair • New atrial fibrillation or PA systolic pressure
>50 mm Hg • Class IIb (reasonable to consider)
• Symptomatic with EF <30%
©2016 MFMER | slide-18
Mitral Valve Surgery for Severe Regurgitation Indications for SECONDARY regurgitation
• Class I (strongest recommendation) • None
• Class IIa (should do for most patients) • None
• Class IIb (reasonable to consider) • Class III-IV symptoms
![Page 4: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/4.jpg)
10/3/16
4
©2016 MFMER | slide-19
Treatment Mitral Valve Repair vs Replacement
CP908602- 19
0
20
40
60
80
100
0 2 4 6 8 10
Expected
Replacement Repair
P=0.0004
Overall survival (%)
Years
68%
52%
©2016 MFMER | slide-20
Contemporary Mitral Valve Repair Triangular Resection with Annuloplasty Band
Sarano, Lancet 2009
©2016 MFMER | slide-21
Alfieri Mitral Valve Repair
Feldman et al. JACC 2009 ©2016 MFMER | slide-22
Transcatheter Edge-to-Edge Mitral Valve Repair
MitraClip Animation
©2016 MFMER | slide-23
Transcatheter Mitral Valve Repair Edge-to-edge Repair
• Approved in high risk primary mitral regurgitation
• Ongoing studies in secondary (functional) mitral regurgitation
• Improves symptoms and survival
• Compared to open MV repair: • Similar NYHA class at 4 years • Similar survival at 4 years • More likely to need open reoperation
Mirabel et al EHJ 2007 Feldman et al NEJM 2011 Mauri et al JACC 2013 ©2016 MFMER | slide-24
3D Echocardiography (TEE) allows visualization of the Mitral Valve
![Page 5: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/5.jpg)
10/3/16
5
©2016 MFMER | slide-25
3D Echocardiography: Clinical Application Evaluating Mitral Valve Pathology
©2016 MFMER | slide-26
©2016 MFMER | slide-27
Echocardiography-Fluoroscopy Fusion MitraClip Guidance
©2016 MFMER | slide-28
MitraClip Therapy for Mitral Regurgitation NYHA Functional Class
Mauri et al. JACC 2013
©2016 MFMER | slide-29
MitraClip Therapy for Mitral Regurgitation Mitral Regurgitation Severity
Mauri et al. JACC 2013 ©2016 MFMER | slide-30
MitraClip Therapy for Mitral Regurgitation Survival compared to mitral valve repair
Mauri et al. JACC 2013
![Page 6: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/6.jpg)
10/3/16
6
©2016 MFMER | slide-31
Transcatheter Mitral Valve Repair Pre-procedural Considerations
Feldman et al NEJM 2011 ©2016 MFMER | slide-32
66 year old male with severe exertional dyspnea, referred for MitraClip.
• Past medical history: • Severe primary mitral regurgitation • CAD with prior coronary bypass operation • Moderate COPD • Chronic atrial fibrillation, on warfarin • Obesity • Hypertension • Hyperlipidemia • Chronic anemia
©2016 MFMER | slide-33
Transcatheter Mitral Valve Repair Mechanism and Location of Jet
©2016 MFMER | slide-34
Transcatheter Mitral Valve Repair Procedural Guidance
Feldman et al. NEJM 2011
©2016 MFMER | slide-35
Transcatheter Mitral Valve Repair Post-Procedural Assessment
Based on the result shown (right), which of the following is the most appropriate next step: A. End the procedure, there is only
mild residual regurgitation. B. Continue the procedure, try
another clip C. Refer the patient for mitral valve
replacement D. Refer the patient for open mitral
valve repair
©2016 MFMER | slide-36
Transcatheter Mitral Valve Repair Second Clip
![Page 7: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/7.jpg)
10/3/16
7
©2016 MFMER | slide-37
Transcatheter Mitral Valve Repair Third Clip, Final Result
First Clip
©2016 MFMER | slide-38
Transcatheter Mitral Valve Repair Procedural Details • Procedural time 1-4 hours • Hospital length of stay 3 days • 87% discharged to home
©2016 MFMER | slide-39
Transcatheter Mitral Valve Repair Potential Complications
• Stroke (1%) • Partial clip detachment (2%) • Mitral stenosis (0.5%) • Pericardial tamponade (2%) • Device embolization (rare) • Injury to atrial septum (rare)
©2016 MFMER | slide-40
Benefits of Cardiac Rehab After MitraClip?
©2016 MFMER | slide-41
Cardiac Rehab After Open Heart Surgery Benefits After Heart Valve Surgery
• Increased rates of return to work • Improved aerobic capacity/6 minute walk • Improved quality of life scores • Decreased rates of anxiety/depression
• Cost neutral • Adverse events rare
©2016 MFMER | slide-42
Cardiac Rehabilitation Post-MitraClip • No data on benefit in post-MitraClip patients • Could we infer benefit based on the typical
profile of a MitraClip patient? • Could we extrapolate data from other minimally
invasive valve procedures with similar patient demographics? e.g. Transcatheter aortic valve replacement
![Page 8: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/8.jpg)
10/3/16
8
©2016 MFMER | slide-43
Cardiac Rehabilitation Post-MitraClip Patient Considerations
• Frequent concurrent heart failure • High risk for readmission • Frequent atrial arrhythmias/atrial fibrillation • Frequently:
• Frail • Deconditioned • Multiple comorbities
• Increased rates of depression, anxiety, lower sense of physical well-being1
1Nikendi et al. Psychosomatic Med 2016 ©2016 MFMER | slide-44
Cardiac Rehabilitation After TAVR Improved 6 minute walk
Voller et al. Eur J Prev Cardiol 2015
©2016 MFMER | slide-45
Cardiac Rehabilitation After TAVR Improved maximal exercise capacity
Voller et al. Eur J Prev Cardiol 2015 ©2016 MFMER | slide-46
Post-MitraClip Restrictions • No driving for 24 hours (sedation) • Shower after 24 hours, bathtub after 48
hours • For 3 days, avoid the following:
• Activities that involve straining • Lifting more than 10 lbs • Strenuous activities
• **No sternotomy restrictions!
©2016 MFMER | slide-47
Summary • Mitral regurgitation is among the most
frequent valve lesions affecting elderly individuals.
• Individuals are frequently not referred to surgery due to ….
• Transcatheter mitral valve repair (MitraClip) is an option for some patients with severe mitral regurgitation at high surgical risk.
©2016 MFMER | slide-48
Summary • Post-MitraClip patients are frequently elderly,
frail, deconditioned, and often have multiple comorbidities:
• No data is currently available supporting cardiac rehabilitation in Post-MitraClip patients, however:
• Data indicate multiple benefits in patients after open mitral valve repair/replacement
• Data indicate cardiac rehabilitation is safe and efficatious in post-TAVR patients (similar demographic to MitraClip patients)
![Page 9: Thaden.Presentation - Mnacvpr10/3/16 4 ©2016 MFMER | slide-19 Treatment Mitral Valve Repair vs Replacement CP908602- 19 0 20 40 60 80 100 0 2 4 6 8 10 Expected Replacement Repair](https://reader033.vdocuments.us/reader033/viewer/2022060410/5f10693b7e708231d448fa10/html5/thumbnails/9.jpg)
10/3/16
9
©2016 MFMER | slide-49
Comments/Questions….